| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 316,905 | 286,700 | | Cost of Revenue | 267,022 | 245,645 | | | Gross Profit | 49,883 | 41,055 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | (58,175) | 15,830 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 108,058 | 25,225 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,250) |
-
| | Earnings Before Interest And Taxes | 101,808 | 25,225 | | Interest Expense | 3,431 | 3,563 | | Income Before Tax | 98,377 | 21,662 | | Income Tax Expense | 22,929 | 8,015 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 75,448 | 13,647 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 75,448 | 13,647 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $75,448 | $13,647 |
|
0.01% Nasdaq 
Income Statement
